The use of oral antibiotics before isotretinoin therapy in patients with acne - 15/01/16
Abstract |
Background |
Systemic antibiotics are used widely to treat moderate to severe acne, but increasing antibiotic resistance makes appropriate use a priority.
Objective |
We sought to determine the duration of systemic antibiotic use in patients with inflammatory/nodulocystic acne who eventually required isotretinoin.
Methods |
We performed a retrospective, single-site chart review of patients with acne diagnostic codes evaluated January 1, 2005 to December 31, 2014, at a dermatology practice in an academic medical center. Included patients were prescribed isotretinoin during the study period and received 30 days or more of antibiotics.
Results |
The average duration of antibiotic use was 331.3 days. In all, 21 patients (15.3%) were prescribed antibiotics for 3 months or less, 88 patients (64.2%) for 6 months or more, and 46 patients (33.6%) for 1 year or longer. Patients treated only at the study site had a mean duration of antibiotic treatment of 283.1 days whereas patients who also received antibiotics from another institution had a mean duration of 380.2 days. This difference approached statistical significance (P = .054).
Limitations |
This study was limited to a single center.
Conclusion |
Expert guidelines recommend responsible use of antibiotics in acne in light of emerging resistance. We found that patients who eventually received isotretinoin had extended exposure to antibiotics, exceeding recommendations. Early recognition of antibiotic failure and the need for isotretinoin can curtail antibiotic use.
Le texte complet de cet article est disponible en PDF.Key words : acne, antimicrobial resistance, isotretinoin, systemic antibiotics
Plan
| Funding sources: None. |
|
| Disclosure: In the past 12 months, Dr Orlow served as a consultant for Dermira, Galderma, GSK/Stiefel, and Provectus, and as an investigator for Amgen. Dr Nagler and Ms Milam have no conflicts of interest to declare. |
Vol 74 - N° 2
P. 273-279 - février 2016 Retour au numéro
Article précédent
- American Board of Dermatology Examination Dates
- Long-term safety and efficacy of etanercept in children and adolescents with plaque psoriasis
- Amy S. Paller, Elaine C. Siegfried, David M. Pariser, Kara Creamer Rice, Mona Trivedi, Jan Iles, David H. Collier, Greg Kricorian, Richard G. Langley
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?